Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unified Code Name System for Drugs Set for Year-end Launch (China)

This article was originally published in PharmAsia News

Executive Summary

Wang Jinxia, vice chairman of the China Association of Pharmaceutical Commerce, says that China will launch a long-awaited unified code name system in the pharmaceutical industry as soon as the end of 2007. Wang is one of three people responsible for drafting the system. All drugs in China will be included in the new system and each medicine will be given a code name for wide recognition and digital management. "Everything is ready (for the system) and it only needs government bureaus' approval," Wang said during a Sinopharm Medicine Holdings Co. event to adopt a new IT system. Previously, drugs in China were written in Chinese, English, Latin or just numbers, lacking a unified code name system. Preparations for the system were first undertaken in 1997 but implementation has been delayed due to bureaucratic infighting over control of the system. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC065726

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel